Pulse Biosciences, Inc. (PLSE) Shareholder/Analyst Call April 25, 2026 1:45 PM EDT
Company Participants
Paul LaViolette – President, CEO & Co-Chairman of the Board
Robert Duggan
Darrin Uecker – CTO & Director
David Kenigsberg – Chief Medical Officer
Liane Teplitsky – Chief Operating Officer
Conference Call Participants
Anthony Petrone – Mizuho Securities USA LLC, Research Division
Joshua Jennings – TD Cowen, Research Division
Presentation
Paul LaViolette
President, CEO & Co-Chairman of the Board
Good afternoon, everybody. I’m Paul LaViolette, Chief Executive Officer of Pulse Biosciences. Really proud to have this gathering at HRS. We’ve been trying to provide updates at every single critical meeting on the itinerary symposium. And today represents a really nice opportunity for us to see you again.
Before we dive in, I just want to introduce a few of the Pulse members who will not be presenting today. I’ll be joined by Dr. Kenigsberg and Darrin Uecker, momentarily, our Chief Medical Officer, Chief Technology Officer, respectively. I want to introduce Bob Duggan. Bob is our Chairman, our principal investor and really the visionary for the last decade behind the establishment of nsPFA as a next-generation energy to ablate in EP and many other parts of the body, as you’re aware.
Robert Duggan
And I’ll defer to Darrin Uecker always.
Paul LaViolette
President, CEO & Co-Chairman of the Board
Darrin is our Bob whisperer. I also want to introduce Liane Teplitsky. There she is, Liane. Liane has just joined us as Chief Operating Officer. Liane has a pronounced career in med tech, but emphatically 18 or so years in the EP space. Knows many of our clinicians, knows the AFib technology area intimately. We’re super happy to have her join and to add some extra horsepower in the drive of our clinical, regulatory and commercial areas.
Also joining Jon Skinner, our
You must be logged in to post a comment Login